Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity.
Hess S, Linde Y, Ovadia O, Safrai E, Shalev DE, Swed A, Halbfinger E, Lapidot T, Winkler I, Gabinet Y, Faier A, Yarden D, Xiang Z, Portillo FP, Haskell-Luevano C, Gilon C, Hoffman A.
Hess S, et al. Among authors: gilon c.
J Med Chem. 2008 Feb 28;51(4):1026-34. doi: 10.1021/jm701093y. Epub 2008 Jan 26.
J Med Chem. 2008.
PMID: 18220330